Another dual PI3K/mTOR inhibitor, PI-103, an effective monotherapy for glioma [34], was recently shown to specifically reduce tumor volumes in combination with Neural stem cell delivered s-trail in an orthotopic intracranial xenograft model [34]. The gene discussed is MTOR; the disease is glioma.